Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical isoniazid versus placebo for melasma
IRCT20211125053175N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in melasma comparing Topical isoniazid 10% with Placebo cold cream (2 arms). Primary endpoints: Melanin content, Erythema content and 3 more. Started Feb 2022; status: completed.
02
Drugs
isoniazid
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20211125053175N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211125053175N1.